FDA Confirms Approval of Gilead's Zydelig; FDA Approves Eagle Pharmaceuticals' Ryanodex

Print E-mail
By Staff and canada viagra generic Wire Reports   
Wednesday, 23 July 2014 19:19
Below is a look at some of the cost of cialis headlines for companies that made news in the generic sample pacs of viagra healthcare sector on July 23, 2014.
Read more...
 

Healthcare Review: Biogen Idec, Inovio Pharmaceuticals, Intuitive Surgical, Puma Biotechnology, Gilead Sciences

Print E-mail
By Staff and Wire Reports   
Wednesday, 23 July 2014 13:28
U.S. stock indexes were mostly higher in early-afternoon trading Wednesday as investors weighed positive earnings from the buy pfizer viagra in canada technology industry against disappointing news from Boeing and cialis generic other companies.
Read more...
 

Puma Bio More Than $100 After-Hours On Trial PB272; CEL-SCI Receives Regulatory Clearance To Expand Phase III Head And cialis from canda Neck Cancer Trial

Print E-mail
By Staff and Wire Reports   
Tuesday, 22 July 2014 19:50
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 22, 2014.
Read more...
 

Synta Announces Ganetespib Into Phase 3 Extension Of AML LI-1 Study; Ignyta Announces Phase I/II Clinical Trial Of RXDX-101

Print E-mail
By Staff and Wire Reports   
Monday, 21 July 2014 19:14
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 21, 2014.
Read more...
 

Healthcare Review: Herbalife, Zynex, Sequenom, Cancer Genetics, Anacor Pharmaceuticals

Print E-mail
By Staff and Wire Reports   
Monday, 21 July 2014 14:01
U.S. stocks fell on Monday, following the canadian pharmacy viagra no prescription sharpest moves in indexes in the past three months during the viagra generic brand two previous sessions, as developments in Ukraine and viagra free pills sample Gaza continue to garner investor focus.
Read more...
 

Salix and cheap no scrip viagra Pharming Announce FDA Approval of RUCONESTĀ®; Lannett Signs Agreement to Be Exclusive U.S. Distributor of ACEONĀ®

Print E-mail
By Staff and Wire Reports   
Friday, 18 July 2014 19:16
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 18, 2014.
Read more...
 

Healthcare Review: Herbalife, Regulus Therapeutics, Supreme Pharmaceuticals, Rexahn Pharmaceuticals, Gentiva Health Services

Print E-mail
By Staff and Wire Reports   
Friday, 18 July 2014 13:30
U.S. stocks rebounded and generic viagra online European markets recovered a bit on Friday but the euro dipped below $1.35 for first time since February after a Malaysian airliner was downed in eastern Ukraine and Israel stepped up a ground assault in Gaza.
Read more...
 

BrainStorm's Clinical Trial is Fast-Tracked to Phase IIa; CEL-SCI Expands Its Phase III Head and Neck Cancer Trial

Print E-mail
By Staff and Wire Reports   
Thursday, 17 July 2014 18:20
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 17, 2014.
Read more...
 

Healthcare Review: Herbalife, Vanda Pharmaceuticals, NeoGenomics, Ensign Group, BioLife Solutions

Print E-mail
By Staff and Wire Reports   
Thursday, 17 July 2014 13:20
U.S. stocks edged lower on Thursday in the wake of fresh U.S. and European Union sanctions on Russia, but some stronger-than-expected earnings reports helped keep declines in check.
Read more...
 

FDA Confirms Endpoints of Androxal Study; Paladin Labs Announces the Canadian Launch of VeregenĀ®

Print E-mail
By Staff and Wire Reports   
Wednesday, 16 July 2014 19:40
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 16, 2014.
Read more...
 
<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>

Page 1 of 343
BioMedReports Expert Briefing: New Immunotherapy Technologies Provide Hope In Breast and viagra doses Ovarian Cancer: Last month, TapImm... http://t.co/AbDQxOYIPC
BioMedReports Can Good News Flow To Continue for CEL-SCI?: Yesterday morning, CEL-SCI Corporation (NYSE MKT: CVM) announced... http://t.co/1rVGKxZznt
BioMedReports Puma Bio More Than $100 After-Hours On Trial PB272; CEL-SCI Receives Regulatory Clearance To Expand Phase III ... http://t.co/C4MJBrrwSo
navigation
Benzinga.com supporter Seeking Alpha Certified